NEW YORK(GenomeWeb) – Wafergen Biosystems today filed a shelf registration to offer up to $30 million of securities from time to time. 

Wafergen President and CEO Ivan Trifunovich told GenomeWeb that there are no imminent financing plans. In August, the firm raised $20 million in gross proceeds through an offering of its common stock and warrants.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.